Cosentyx unoready 300 MG pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F21HJ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $58,300
Award facts
- Contract value 100% obligated
- $58,299.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $58,299.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Cosentyx (secukinumab) 300 mg pens on January 27, 2026, with completion expected by January 28, 2026. This delivery order is a child contract executed under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2031. The contract carries no set-aside designation and was competitively awarded. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
Cosentyx is a biologic immunosuppressant medication used to treat autoimmune and inflammatory conditions including psoriasis, psoriatic arthritis, and ankylosing spondylitis. This procurement supports DLA's mission to supply pharmaceutical products for military healthcare systems and treatment facilities worldwide. AmerisourceBergen, a major pharmaceutical distributor and critical vendor for federal medical procurement, regularly fulfills such orders through its comprehensive IDC vehicle that enables flexible delivery of specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains to support Defense Health Agency operations and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F21HJ?
SPE2DR26F21HJ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 27, 2026.
How much is contract SPE2DR26F21HJ worth?
The government has obligated $58,300 on SPE2DR26F21HJ.
Is contract SPE2DR26F21HJ an order under another contract?
Yes. SPE2DR26F21HJ is a delivery order under SPE2DR25D3301, an indefinite delivery contract.
Was contract SPE2DR26F21HJ competed?
The extent of competition for SPE2DR26F21HJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award